Evidence map›Paper›PMID 26114754›Full record

ArticlePloS one2015

LPS-Induced G-CSF Expression in Macrophages Is Mediated by ERK2, but Not ERK1.

Shwu-Fen Chang, Shih-Shan Lin, Hui-Ching Yang, Yuan-Yi Chou, Jhen-I Gao, Shao-Chun Lu

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Human β-Defensin 3 InhibitsInternational journal of molecular sciences · 2022
    Article
  10. Article
  11. Article
  12. Article
  13. SBT (Composed ofAntioxidants (Basel, Switzerland) · 2022
    Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. ERK1 and ERK2 Map Kinases: Specific Roles or Functional Redundancy?Frontiers in cell and developmental biology · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Shwu-Fen ChangGraduate Institute of Medical Sciences, School of Medicine, Taipei Medical University, Taipei, Taiwan.
Shih-Shan LinDepartment of Biochemistry and Molecular Biology, College of Medicine, National Taiwan University, Taipei, Taiwan.
Hui-Ching YangDepartment of Biochemistry and Molecular Biology, College of Medicine, National Taiwan University, Taipei, Taiwan.
Yuan-Yi ChouDepartment of Biochemistry and Molecular Biology, College of Medicine, National Taiwan University, Taipei, Taiwan.
Jhen-I GaoDepartment of Biochemistry and Molecular Biology, College of Medicine, National Taiwan University, Taipei, Taiwan.
Shao-Chun LuDepartment of Biochemistry and Molecular Biology, College of Medicine, National Taiwan University, Taipei, Taiwan.
National Taiwan University · TWTaipei Medical University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Granulocyte colony-stimulating factor (G-CSF) selectively stimulates proliferation and differentiation of neutrophil progenitors which play important roles in host defense against infectious agents. However, persistent G-CSF production often leads to neutrophilia and excessive inflammatory reactions. There is therefore a need to understand the mechanism regulating G-CSF expression. In this study, we showed that U0126, a MEK1/2 inhibitor, decreases lipopolysaccharide (LPS)-stimulated G-CSF promoter activity, mRNA expression and protein secretion. Using short hairpin RNA knockdown, we demonstrated that ERK2, and not ERK1, involves in LPS-induced G-CSF expression, but not LPS-regulated expression of TNF-α. Reporter assays showed that ERK2 and C/EBPβ synergistically activate G-CSF promoter activity. Further chromatin immunoprecipitation (ChIP) assays revealed that U0126 inhibits LPS-induced binding of NF-κB (p50/p65) and C/EBPβ to the G-CSF promoter, but not their nuclear protein levels. Knockdown of ERK2 inhibits LPS-induced accessibility of the G-CSF promoter region to DNase I, suggesting that chromatin remodeling may occur. These findings clarify that ERK2, rather than ERK1, mediates LPS-induced G-CSF expression in macrophages by remodeling chromatin, and stimulates C/EBPβ-dependent activation of the G-CSF promoter. This study provides a potential target for regulating G-CSF expression.

Indexed as

Gene ExpressionAnimalsButadienesCCAAT-Enhancer-Binding Protein-betaCell LineDeoxyribonucleasesExtracellular Signal-Regulated MAP KinasesGene Knockdown TechniquesGranulocyte Colony-Stimulating FactorLipopolysaccharidesMacrophagesMiceMitogen-Activated Protein Kinase 1NF-kappa BNitrilesPromoter Regions, GeneticButadienesCCAAT-Enhancer-Binding Protein-betaDeoxyribonucleasesExtracellular Signal-Regulated MAP KinasesGranulocyte Colony-Stimulating FactorLipopolysaccharidesMitogen-Activated Protein Kinase 1NF-kappa BNitrilesProtein Kinase InhibitorsU 0126

Identifiers

PMID26114754
PMCPMC4483241
OpenAlexW1492714130

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.